renin; renin-angiotensin system; endocrinology; hypertension; proteolysis; lysosomes THE RENIN-ANGIOTENSIN SYSTEM (RAS) plays a crucial role in the regulation of blood pressure and fluid volume through the synthesis of the potent vasoactive peptide angiotensin II. Renin is an aspartyl protease that catalyzes the rate-limiting step in the RAS. Like other proteases, renin is first produced as an enzymatically inactive zymogen called prorenin. Whereas circulating renin virtually disappears after bilateral nephrectomy, the inactive prorenin can persist in the circulation for years (3) , demonstrating that the kidney is the primary source of proteolytically active renin.
In the kidney, renin is secreted by the highly specialized juxtaglomerular (JG) cells, where it is activated and stored in dense cytoplasmic granules until the cells receive a signal for its release. The dense granules of JG cells are different from those found in most endocrine cells; they are large vacuolar cisternae that occupy up to half of the cytoplasmic space, contain several lysosomal enzymes, and release renin acutely by a process that is poorly understood but proposed to include compound exocytosis (27) . It is within these granules that the conversion of prorenin to renin occurs by the proteolytic removal of an NH 2 -terminal prosegment through the action of a second protease (28) . Although its exact identity is a matter of much debate, this protease activity is commonly referred to as the "prorenin-processing enzyme" (PPE). Analogous to the known mechanism of proteolytic activation of other many other proprotein precursors (24) , it has been suggested that the unique ability of the JG cells to activate prorenin might be due to their unique expression of a PPE that can cleave the prorenin prosegment at a specific site.
Because JG cells rapidly dedifferentiate when removed from the kidney, it has been difficult to establish a cell culture model to aid in the identification of the PPE (13, 22) . Nevertheless, some evidence has suggested that cathepsin B (CTSB) could be a PPE for human prorenin; it was identified as the enzyme present in extracts of human cadaver kidney that was capable of activating prorenin (30) , it generates the same amino terminus in vitro as that reported for renin purified from human kidney (7) , and it colocalizes with renin in the JG granules of humans and rats (16, 25) . However, mice deficient for CTSB show no defect in their ability to generate active renin (17) , and rats made hypertensive through a humanized RAS do not display a change in blood pressure when treated with a specific CTSB inhibitor (21) . These results raise doubts as to whether CTSB is either bona fide or the only PPE.
In the current study, we have used a combination of approaches to attempt the characterization of the mouse prorenin (Ren1) PPE. Our results demonstrate that mouse prorenin can be processed accurately within standard lysosomes from a heterologous cell type. The implication of our study is that specificity of active renin production may not result from a restriction of PPE expression to JG cells.
MATERIALS AND METHODS
Animals. The mice used in this study were housed on a 10:14-h light-dark cycle with free access to normal mouse chow and water. All of the experiments described herein were approved by the institutional Animal Ethics Committee and are in compliance with guidelines issued by the Canadian Council on Animal Care. C57BL/6 mice were obtained commercially from Harlan-Teklad (Lachine, QC, Canada) and bred in a specific pathogen-free facility. All animals studied were of mixed sex at 8 -12 wk of age unless otherwise stated.
Preparation of kidney lysates. For preparation of kidney cortex lysates, mice were euthanized by CO 2 inhalation, the kidneys were immediately removed and decapsulated, and the papilla were cut away. The cortices were cut into 1-to 2-mm blocks, washed in ice-cold phosphate-buffered saline (PBS), and pressed through a 150-m nylon screen using a rubber policeman. The dispersed cortices were resuspended in PBS to a final volume of 1 ml/kidney. Nonidet P-40 (NP-40; Fluka Biochemika, Buchs, Switzerland) was added to a final concentration of 0.1%, and the crude suspension homogenized with 10 strokes of a Konte Teflon/glass mortar and pestle on ice. The crude lysate was spun at 1,000 g in a microfuge for 1 min, and the supernatant was carefully removed and transferred to a new tube. This is the crude kidney cortex lysate.
Immunoprecipitation of renal renin. For renin purification, sodium dodecyl sulfate (SDS) was added to the crude kidney cortex lysate at a final concentration of 0.1%, and the mixture was spun at 13,000 rpm in a microfuge for 10 min at 4°C to pellet cellular debris and DNA. NP-40 was added at a final concentration of 1%, and sheep anti-(rat) prorenin/renin antibody immobilized on sepharose (10 l/ml lysate; Molecular Innovations, Novi, MI) was added to capture prorenin and renin. After extensive washing, the immunoprecipitate was released from the beads by boiling in SDS-PAGE sample buffer and separated by electrophoresis.
Western blot analysis. For Western blotting, the proteins were transferred to nitrocellulose, and the following antibodies (suppliers and dilutions) were used for protein detection: Bri6 rabbit polyclonal anti-renin/prorenin (1/4,000), rabbit anti-c-myc (C3956, 1/2,000; Sigma), mouse anti V5-horseradish peroxidase (HRP; 376609, 1/5,000; Invitrogen), rabbit anti-GAPDH (sc-25778, 1/2,000; Santa Cruz Biotechnology), and donkey anti-rabbit IgG-HRP (1/10,000, NA934V; GE Healthcare). HRP was detected using a chemiluminescent assay (Amersham ECL Advance) according to the manufacturer's instructions.
NH 2-terminal sequencing of mouse kidney renin. Samples containing immunoprecipitated renin from mouse kidney cortex were fractionated by SDS-PAGE gel electrophoresis and transferred to an Immobilon-P membrane. The filter was stained briefly with Coomassie blue, and the band corresponding to renin was excised, rinsed thoroughly with water, and dried. Automated Edman degradation was carried out according to the manufacturer's protocol using an Applied Biosystems (Foster City, CA) Procise sequencer (model 494-cLC).
Determination of plasma renin concentration. Renin activity was determined by the angiotensin I generation assay. Sixty microliters of blood were collected by retroorbital puncture using a heparinized microhematocrit capillary pipette (Fisher Scientific, Pittsburgh, PA) from mice that had been lightly anesthetized with ether. EDTA was added to a final concentration of 15 mM, and the plasma fraction was separated immediately by centrifugation. Plasma renin concentration was measured by diluting plasma from untreated (1:100) and captopril-treated (1:1,000) mice in 100 l of buffer containing 0.1 M potassium phosphate (pH 7.4), 0.1 M malic acid (pH 6.5), 0.1 M NaCl, 0.25% bovine serum albumin, 0.02% NaN3, 3 mM EDTA, 0.03% 8-hydroxyquinoline, and 0.5 mM phenylmethylsulfanyl fluoride. Five microliters of nephrectomized sheep serum containing an excess of angiotensinogen (equivalent to 1,000 pg angiotensin I) were added, and the samples were incubated for 1 h at 37°C. The angiotensin I generated was quantified by radioimmunoassay.
Microarray expression analysis. Twelve-week-old male mice were treated for 7 days with the angiotensin-converting enzyme inhibitor captopril (Sigma-Aldrich, Oakville, ON, Canada) at a dose of 10 mg·kg Ϫ1 ·day Ϫ1 in drinking water. At the end of the treatment period, total kidney RNA was isolated using TRIzol (Invitrogen) from three treated and three control mice and was further purified using RNeasy MinElute Cleanup spin columns (Qiagen) according to manufacturer's instructions. Probes generated from the resulting RNA were hybridized to Illumina Expression BeadChips (mouseWG-6_V2) at the McGill Genome Center. The resulting data were analyzed using FlexArray software (http://genomequebec.mcgill.ca/FlexArray). The microarray data were deposited in the GEO database with accession no. GSE57239 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?accϭ GSE57239).
Immunofluorescence. Mice were euthanized by CO2 inhalation. The kidneys were removed immediately and decapsulated, fixed in Bouin's fixative, and imbedded in paraffin. After rehydratation, 5-m slide-mounted sections were washed in TBS and preincubated in a blocking solution [TBS with 1% of normal donkey serum (NDS); Sigma] for 1 h at room temperature. The sections were incubated overnight at 4°C in TBS containing 5% NDS and a mixture of sheep anti-rat prorenin/renin (Molecular Innovations) antibody diluted 1/1,000 and rabbit polyclonal anti LAMP-1 (24170; Abcam) antibody diluted 1/1,000. The sections were then rinsed in TBS and incubated with Alexa 555-coupled goat anti-rabbit and Alexa 488-coupled donkey anti-sheep antibodies (Molecular Probes, Eugene, OR) diluted 1/500 in TBS containing 5% NDS.
For transfected cells the methods were the same, except that cells were fixed and permeabilized by incubation in absolute methanol at Ϫ20°C for 10 min. All of the samples were mounted in Vectashield with DAPI (no. H-1200; Vector Laboratories, Burlingame, CA).
Labeled specimens were scanned with an LSM700 confocal laser scanning microscope (Carl Zeiss) linked to an AxioObserver Z.1 (Carl Zeiss). For the high-magnification images, a ϫ63 oil objective was used with a numerical aperture of 1.4, and for the low-magnification images we used a ϫ20 objective with a numerical aperture of 0. high-pass portion of the adjustable dichroic set to 559 nm. There was no cross-bleeding of the Alexa 488 and 555 dye signals as determined by staining the samples with renin and LAMP-1 antibodies alone (Fig.  3 ). The DIC image was acquired using the transmitted light photomultiplier tube.
Expression vector construction. The mouse Ren1 prorenin coding sequence was amplified by PCR from C57BL/6 mouse kidney cDNA and was inserted into the pIRES2-EGFP vector (Clontech, Palo Alto, CA) either with its native stop codon or as an in-frame fusion, with the coding sequence for the v5 epitope and the last 35 amino acids and the COOH terminus of LAMP-1 (containing the transmembrane domain and lysosomal sorting signal; Fig. 4A ) or with the c-myc or v5 epitope (Fig. 5 ). All protein-coding sequences were verified by DNA sequencing in their entirety.
Cell culture and transfection. Human embryonic kidney (HEK)-293 cells were cultured in Dulbecco's modified Eagle's medium/highglucose medium (GIBCO) supplemented with 10% fetal calf serum and gentamicin (Invitrogen). Transient transfection was performed using Effectene Transfection Reagent (Qiagen) according to the manufacturer's recommendations. Forty-eight hours after transfection, the supernatants were collected and spun to remove cell debris, and cells were trypsinized, pelleted, and lysed in TBS, 1 M NaCl, and 0.1% Triton X-100 supplemented with a protease inhibitor cocktail tablet (Complete Mini, EDTA free; Roche) prior to immunoprecipitation using sheep anti-rat prorenin/renin antibody immobilized on sepharose (10 l/ml of lysate; Molecular Innovations), as described above.
NH2-terminal sequencing of mouse renin from transfected HEK cells.
Immunoprecipitation was performed on lysates of HEK-293 cells transfected with an expression vector for mouse Ren1 prorenin, as described above. Immunoprecipitated proteins were fractionated on a 10% polyacrylamide SDS-PAGE gel. The band corresponding to renin was excised from the silver-stained polyacrylamide gel and digested in-gel with trypsin. The resulting peptides were fractionated by HPLC (Proxeon Biosystems, Odense, Denmark) coupled to the LTQ Orbitrap Velos (ThermoFisher Scientific, Bremen, Germany) equipped with a Proxeon nanoelectrospray ion source. Protein database searching was performed with Mascot 2.2 (Matrix Science) against the human NCBInr protein database. The mass tolerances for precursor and fragment ions were set to 10 ppm and 0.6 Da, respectively. Trypsin was used as the enzyme, allowing for up to two missed cleavages. Carbamidomethyl and oxidation of methionine were allowed as variable modifications.
Renin stability. For estimation of renin stability, crude kidney lysate was incubated at 37°C for Յ2 h. The digestion was stopped by addition of SDS at a final concentration of 0.1%, and the lysate was cleared by centrifugation at 13,000 rpm in a microfuge for 10 min at 4°C. Ten micrograms of protein from the cleared lysate were separated by SDS-PAGE, and the contents of the gel were transferred onto a nitrocellulose membrane for Western blot analysis. Renin and GAPDH signals were quantitated using Image Lab (Bio-Rad) software. Statistical analysis. Statistical analysis was performed using GraphPad Prism version 5.0 for Windows (GraphPad Software, San Diego, CA), using one-way ANOVA with Bonferroni's multiple comparison posttest. Results were considered significant at P Ͻ 0.05.
RESULTS

Identification of the amino terminus of mouse kidney renin.
To characterize the mouse PPE activity, it was first necessary to identify the bona fide amino terminus of mouse kidney renin. We have carried out the study in the C57BL/6 strain of mice whose genome codes for only a single (Ren1) gene. All strains of laboratory mice express the Ren1 gene, whereas mice descended from the Swiss strain have a second renin gene called Ren2 (6) . Unlike renin in humans and rats and its true homolog Ren1 in mice, Ren2 is not glycosylated, it is expressed at high levels in the submandibullar gland, and it can be activated by enzymes that do not cleave Ren1, human, or rat prorenins (12, 20) . For this reason, we used a mouse strain that would exclude Ren2 from the analysis.
To determine the amino terminus of mouse kidney Ren1, we immunopurified renin from whole kidney cortex lysates (Fig. 1A) and subjected it to automated Edman degradation. The results (Fig. 1B) reveal that active mouse kidney renin begins at amino acid 72 (serine). This is identical to the position reported previously for intracellular mouse renin purified from transformed As4.1 cells (11) and analogous to the position reported for rat kidney renin (4). This result demonstrates that both rat and mouse (Ren1) kidney renin have amino termini that are eight amino acids "downstream" of the position reported for human kidney renin (7) (Fig. 1C) .
Assay for proteases that increase with renin production. Treatment of mice for 1 wk with the converting enzyme inhibitor captopril causes a dramatic (15-20 times) increase in circulating active renin ( Fig. 2A) that results in part from a recruitment of new JG cells by a transformation of neighboring smooth muscle cells in the afferent arterioles. Reasoning that, if JG cells contained a unique and cell-specific PPE, the latter might also be induced by such treatment to match the recruitment of JG cells and keep up with the demand for renin production, we performed a gene expression analysis on the kidneys of mice either with or without captopril treatment. As expected, comparative analysis of the gene expression means from both groups reveals that renin transcripts are increased by roughly fivefold in the captopril-treated kidneys compared with controls (note that the signal for Ren2 is an artifact of hybridization since the mice only express Ren1; Fig. 2B) . Notably, no other kidney transcript shows a greater than 1.5-fold induction with captopril treatment. A list of genes whose expression is changed Ն1.2-fold by captopril treatment (Table 1) includes AKR1B7, a marker of mouse JG cells (2), most likely reflecting the recruitment of new JG cells that results from captopril treatment (14) . Thus, although this assay is limited in its sensitivity by our analysis of whole kidney, we were able to detect the increase in expression of both renin and a JG cell-specific marker (AKR1B7) in response to captopril. Nevertheless, there are no proteases whose expression increases Characterization of renin secretory granules. The granules of JG cells have been called "lysosome-like" since they contain several lysosomal enzymes, including acid phosphatase, ␤-glucuronidase, cathepsins B, H, L, and D and Limp-2 (16, 23, 26, 29) . To test whether JG granules also contain LAMP-1 (lysosomal-associated membrane protein 1; a biomarker of mature lysosomes) (1), sections of kidney cortex were costained with antibodies to renin and LAMP-1 (Fig. 3) . To test the specificity of the immunoreaction and to rule out possible cross-bleeding between chosen fluorophores, kidney sections were immunostained with either renin (Fig. 3, A-C) or LAMP-1 (Fig, 3. D-F) antibodies separately. Lower magnification (ϫ20) shows that anti-renin antibody stains only the JG apparatus (Fig. 3,  A-C) , whereas LAMP-1 staining (Fig. 3, D-F) shows a strong enrichment both in the JG area as well as the parietal layer of Bowman's capsule and in tubules. To test for the colocalization of renin and LAMP-1, kidney sections were stained simultaneously with both antibodies, and single images showing JG apparatus were chosen randomly. High magnification (ϫ63) of the JG apparatus (Fig. 3, G-L) confirmed a marked enrichment of LAMP-1 in the JG apparatus and colocalization with renin, suggesting that renin is stored in LAMP-1-containing lysosomal organelles. Moreover, the pattern of staining of LAMP-1 follows that of renin even in newly recruited JG cells following treatment with captopril (Fig. 3, J-L) . These results add LAMP-1 to the list of lysosomal proteins in the unique granules of JG cells and suggest that renin is colocalized in these organelles with this marker of mature lysosomes.
Processing of prorenin in heterologous lysosomes. One possible explanation for the apparent lack of an increase in the expression of a PPE in captopril-treated mice might be that renin is activated by one or more broadly expressed lysosomal proteases. To test whether cells other than JG cells can process prorenin, we transfected mouse Ren1 prorenin in HEK-293 cells, which were chosen due to their high transfection efficiency and typically high protein expression. Western blot analysis of both supernatant and intracellular content after renin immunoprecipitation (Fig. 4B, left) shows that transfected HEK cells release mainly the unprocessed form of prorenin (Fig. 4B, left, lane 5) , whereas the cell lysate contains both prorenin and a form of renin that migrates at the same molecular weight as that from mouse kidney (compare lanes 4 and 3; Fig. 4B, left) . These results suggest that HEK-293 cells retain a portion of the expressed prorenin in an intracellular compartment that contains a PPE. To test whether this compartment is a lysosome, we used the LAMP-1 COOH-terminal transmembrane domain, which contains the lysosomal targeting motif (1) , to force the targeting of mouse Ren1 prorenin to the classical vesicular lysosomes of cultured HEK-293 cells (Fig. 4A) . Analysis of cell lysates from transfected HEK-293 cells reveals the intracellular retention not only of the fulllength fusion protein (prorenin/V5/LAMP), but also of a form of renin that migrates with a molecular weight similar to that of bona fide mouse kidney renin (Fig. 4B, left, lane 6) . Interestingly, this "mature" form of renin has lost the V5 epitope that precedes the LAMP-1 motif (Fig. 4B, right, lane 6) , suggesting that it has been "trimmed." Likewise, transfection of HEK-293 cells with expression vectors encoding mouse Ren1 prorenin without the LAMP-1 transmembrane domain but with either a myc (Fig. 5A) or a V5 epitope tag (Fig. 5B ) on their COOHtermini results in the intracellular retention of a small amount of renin of seemingly appropriate molecular weight from which the epitope tags have been removed. These results demonstrate that even in the absence of the LAMP-1 extension a portion of prorenin is directed to HEK-293 lysosomes, where both the prosegment and any COOH-terminal extensions are removed to generate a protein of a size compatible with active renin. To test whether the trimming of prorenin in HEK-293 lysosomes results in a correctly processed mouse renin, the band corresponding to mature renin was purified from cell lysates and subjected to LC-MS/MS analysis. Immunostaining of HEK-293 cells transfected with an expression vector for native (unmodified) mouse Ren1 prorenin reveals a significant overlap of renin and LAMP-1 staining in multiple small cytoplasmic vesicles (Fig. 6A) , confirming not only the lysosomal targeting of a portion of the expressed prorenin but also the dramatic difference in the morphology of the small vesicular lysosomes of HEK cells and the large cisternae seen in the JG cells (Fig. 3) . Two prominent protein bands were immunepurified from the transfected HEK cell lysates (Fig. 6B) , and MS/MS analysis confirms that the lower band is active renin. Like mouse kidney renin, the major form of mature Ren1 in the transfected cells begins with amino acid 72, whereas two minor forms begin at amino acids 70 and 71 (Table 2 ). These results demonstrate that correct proteolytic activation of mouse Ren1 prorenin can occur in the classical vesicular lysosomes of non-JG cells from a different species.
Resistance of active renin to proteolytic degradation. One possible explanation for the ability of JG cells to store renin in lysosomes is that it is resistant to degradation by the other resident lysosomal proteases. To test this possibility, crude protein extracts of mouse kidney cortex were incubated in the absence of protease inhibitors at 37°C for Յ2 h, and the resulting digests were separated by SDS-PAGE. Western blot analysis (Fig. 7) revealed that whereas the amount of renin in the lysate decreased minimally over the 2-h incubation period, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), an enzyme of roughly equivalent molecular weight, virtually disappeared in the sample within the same incubation time. These results confirm that mature renin is extraordinarily stable to proteolytic degradation.
DISCUSSION
The major implication of our findings is that the unique ability of the kidney to produce active renin may not require the tissue-specific localization of a PPE in JG cells. In fact, correct renin activation and storage can occur even in the classical lysosomes found in other cell types and whose primary role is to break down waste material and cellular debris. Our findings are consistent with an opportunistic model for prorenin activation in which the actual cleavage site is dictated by a combination of the prolonged exposure of prorenin to a collection of lysosomal hydrolases and a barrier to further degradation of the mature renin. In fact, since the LC-MS/MS analysis carried out on mouse renin produced in transfected HEK-293 identified more than one amino terminus, it is possible that multiple proteases and/or progressive trimming occurs to generate the mature renin. Such "imprecise" cleavage of the prosegment would be capable of producing active renin since the inactive conformation of prorenin is maintained almost entirely by the burial of a single leucine residue at position 13 of the prosegment (18, 19) , which would be lost with any of the cleavage sites reported for human, mouse, and rat renin. Furthermore, the recent report of the three-dimensional structure of human prorenin reveals that the PPE cleavage site is exposed on the surface of the protein, whereas the core of the active renin protease is tightly packaged in a ␤-sheet structure (19) . These properties might explain why the prosegment is digested in lysosomes, whereas the body of mature renin would be protease resistant. Subsequent aggregation of renin to form the dense core of the JG granules may offer further protection to renin from proteolysis. However, although our findings are consistent with a model of limited hydrolysis for the activation of mouse prorenin, we cannot rule out that specific proteases might be responsible for activation of prorenin in other species. The lysosomal processing and resistance to degradation displayed by renin are characteristics shared by the cathepsins, a family of proteases whose role is to degrade other proteins in the lysosomes. Indeed, renin shares 46% homology to the ubiquitously expressed lysosomal aspartyl protease cathepsin D (8), although renin expression has a much more restricted tissue distribution, and angiotensinogen is its only known substrate. In fact, renin has previously been reported to acquire mannose-phosphate residues, a classical lysosomal targeting signal, although we have not tested whether this is the reason that a portion of prorenin is directed to lysosomes in HEK cells even in the absence of the LAMP-1 lysosomal targeting domain. Taken together, these results raise the possibility that renin evolved initially as a nonfunctional cathepsin, a possibility that is not inconsistent with the fact that it was the last component to appear in the evolution of the RAS (9) .
The production of mouse renin by lysosomal hydrolysis would also be consistent with the lysosomal nature of the JG granules and the proposal that cathepsin B participates in the activation of human prorenin. Whereas endocrine cells utilize a dense core secretory granule for storage and regulated exocytosis of some proteins while maintaining a separate lysosomal compartment, some other cell types (including melanocytes and some hematopoietic cells) have merged these two functions into secretory lysosomes (15) . These dual-function organelles resemble lysosomes by virtue of their low pH, similar morphology, and the presence of lysosomal proteins. However, they are distinguishable from lysosomes by their ability to fuse with the plasma membrane in a regulated fashion. The functions of such secretory lysosomes are selectively impaired in several human genetic diseases that include the Chediak-Higashi syndrome (5), which results from a mutation in the Lyst protein. In mice, mutations of the Lyst protein are found in the "beige" mouse, whose JG cells contain giant renin-containing granules and exhibit a mild defect in renin secretion (10) . Altogether, the JG cell renin-processing granules more closely resemble the lysosome-related organelles of melanocytes and hematopoietic cells than the granules of endocrine cells, and this may explain how prorenin can be accurately processed and stored in heterologous lysosomes. As such, the kidney-specific production of active renin is most likely a result of the unique ability of JG cells, compared with other prorenin-expressing tissues, to secrete their lysosomal content in a regulated fashion.
Perspectives and Significance
Our findings suggest that the RAS represents a unique model of peptide hormone synthesis. In classical endocrine pathways, such as those for insulin and ACTH (24) , the substrate and processing protease are expressed in the same cell and have strictly limited tissue distribution. The prohormone convertases are most often autocatalytically activated and interact with their target prohormone within the nascent secretory granules to produce the mature peptide or protein hormone. Regulated secretion of the mature hormone from storage granules then occurs when the cell receives a physiological stimulus. Although the RAS is also exquisitely regulated and tissue restricted, it differs substantially from other protein/peptide endocrine systems in the means by which it generates its active peptide hormone. In the RAS, the substrate (angiotensinogen) and protease (renin) are made in different cell types. The rapid physiological response in levels of the peptide hormone (angiotensin II) is mediated by the acute release of the rate-limiting protease renin, primarily from the JG cells of the kidney. Although several cell types outside the kidney secrete prorenin into the circulation (3), our results suggest that the unique ability of JG cells to secrete active renin is not due to their content of a unique PPE but could conceivably be due to their unique ability, among other prorenin-expressing cells, to secrete their lysosomal content.
